Skip to main content

Australia's VCGS Inks Deal with Illumina to Develop NIPT

NEW YORK (GenomeWeb) – Victorian Clinical Genetics Services, a genetic testing subsidiary of the Murdoch Children's Research Institute in Melbourne, Australia, has struck a deal with Illumina for non-invasive prenatal testing.

Under the agreement, VCGS will develop its own non-invasive prenatal test using Illumina's sequencing technology, which it will begin offering in early 2015. Prior to launching its own test, VCGS will send samples to Illumina for testing. 

"This agreement positions VCGS at the frontier of prenatal testing in Australia, and offers patients exciting and powerful new options for genetic testing," Damien Bruno, deputy laboratory director at VCGS, said in a statement. 

VCGS currently provides maternal serum screening for more than 58,000 women annually. It also offers genetic services, including genetic counseling and education.

Earlier this year, VCGS published on a method in PLOS One to reduce coverage bias from shotgun sequencing in order to improve accuracy of detecting aneuploidy.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.